Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of preeclampsia in pregnant women with low pregnancy-associated plasma protein A
IRCT20191104045328N14Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in preeclampsia comparing Metformin with Placebo (2 arms). Primary endpoints: Liver function enzymes, Systolic blood pressure and 5 more. Started Jan 2023; status: completed.
02
Drugs
metformin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20191104045328N14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191104045328N14.